SCHEMBL7304734

SCHEMBL7304734

CCOC(=O)C(c1ccc(OC)c(OC)c1)C(C[N+](=O)[O-])c1cccc(OC)c1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.54
CYP2C19 P33261 1/20 0.54
LMNA P02545 5/20 0.45
MAPT P10636 4/20 0.41
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
HTT P42858 3/20 0.38
SMN1; SMN2 Q16637 4/20 0.37
HIF1A Q16665 1/20 0.36
GAA P10253 3/20 0.36
KMT2A Q03164 3/20 0.36
RAB9A P51151 3/20 0.36
MAPK1 P28482 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TNF P01375 1/20 0.35
MEN1 O00255 2/20 0.35
NPC1 O15118 2/20 0.35
PKM P14618 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7294942 0.85 CA12 (0.42) ALDH1A1CYP2C19LMNAMAPTCA12
SCHEMBL7296011 0.77 ALDH1A1 (0.55) ALDH1A1CYP2C19LMNAMAPTCA12
SCHEMBL7436053 0.74 ALDH1A1 (0.53) ALDH1A1CYP2C19LMNAMAPTCA12
SCHEMBL7303616 0.73 ALDH1A1 (0.59) ALDH1A1CYP2C19LMNAMAPTCA12
SCHEMBL29896531 0.73 ALDH1A1 (0.52) ALDH1A1CYP2C19LMNAMAPTHTT
SCHEMBL7295115 0.72 GAA (0.48) ALDH1A1CYP2C19LMNAMAPTHIF1A
SCHEMBL18106489 0.71 ALDH1A1 (0.46) ALDH1A1CYP2C19LMNAMAPTHTT
SCHEMBL5518745 0.70 ALDH1A1 (0.63) ALDH1A1CYP2C19LMNAMAPTHTT
SCHEMBL5525324 0.70 ALDH1A1 (0.63) ALDH1A1CYP2C19LMNAMAPTHTT
SCHEMBL4300636 0.69 ALDH1A1 (0.46) ALDH1A1CYP2C19LMNAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5444083-A DOPAMINE AGONIST FOR TREATING OR PREVENTION OF HYPERTENSION OR HEART FAILURE EISAI CO., LTD. (JP) 1995-08-22 US disclosed
EP-0381235-B1 PYRROLIDINE COMPOUND AND PHARMACEUTICAL USE Eisai Co., Ltd. (JP) 1993-07-28 EP disclosed
EP-0381235-A2 Pyrrolidine compound and pharmaceutical use Eisai Co., Ltd. (JP) 1990-08-08 EP disclosed